Clinical trials
Hyperoxaluria, Primary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 1 |
| 2013 | 5 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 8 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Terminated | 1 |
| Not yet recruiting | 1 |
| Approved for marketing | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 10 |
| Alnylam Pharmaceuticals | 6 |
| OxThera | 6 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 5 |
| Biocodex | 2 |
| YolTech Therapeutics Co., Ltd | 2 |
| Allena Pharmaceuticals | 1 |
| Arbor Biotechnologies | 1 |
| Centre Hospitalier Universitaire de Liege | 1 |
| Cystinose Stiftung | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperoxaluria, Primary | 42 |
| Hyperoxaluria | 21 |
| Cystinuria | 6 |
| Dent Disease | 6 |
| Kidney Calculi | 5 |
| Genetic Diseases, Inborn | 4 |
| Kidney Diseases | 4 |
| Urologic Diseases | 4 |
| Cystinosis | 3 |
| Nephrocalcinosis | 3 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.